Your browser doesn't support javascript.
loading
The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor Activation.
Winfield, Ian; Barkan, Kerry; Routledge, Sarah; Robertson, Nathan J; Harris, Matthew; Jazayeri, Ali; Simms, John; Reynolds, Christopher A; Poyner, David R; Ladds, Graham.
Afiliação
  • Winfield I; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
  • Barkan K; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
  • Routledge S; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
  • Robertson NJ; School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
  • Harris M; Sosei Heptares, Cambridge, United Kingdom.
  • Jazayeri A; Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
  • Simms J; Sosei Heptares, Cambridge, United Kingdom.
  • Reynolds CA; School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
  • Poyner DR; Centre of Sports Health and Life Sciences, Coventry University, Coventry, United Kingdom.
  • Ladds G; School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
Front Endocrinol (Lausanne) ; 12: 792912, 2021.
Article em En | MEDLINE | ID: mdl-35095763
The first intracellular loop (ICL1) of G protein-coupled receptors (GPCRs) has received little attention, although there is evidence that, with the 8th helix (H8), it is involved in early conformational changes following receptor activation as well as contacting the G protein ß subunit. In class B1 GPCRs, the distal part of ICL1 contains a conserved R12.48KLRCxR2.46b motif that extends into the base of the second transmembrane helix; this is weakly conserved as a [R/H]12.48KL[R/H] motif in class A GPCRs. In the current study, the role of ICL1 and H8 in signaling through cAMP, iCa2+ and ERK1/2 has been examined in two class B1 GPCRs, using mutagenesis and molecular dynamics. Mutations throughout ICL1 can either enhance or disrupt cAMP production by CGRP at the CGRP receptor. Alanine mutagenesis identified subtle differences with regard elevation of iCa2+, with the distal end of the loop being particularly sensitive. ERK1/2 activation displayed little sensitivity to ICL1 mutation. A broadly similar pattern was observed with the glucagon receptor, although there were differences in significance of individual residues. Extending the study revealed that at the CRF1 receptor, an insertion in ICL1 switched signaling bias between iCa2+ and cAMP. Molecular dynamics suggested that changes in ICL1 altered the conformation of ICL2 and the H8/TM7 junction (ICL4). For H8, alanine mutagenesis showed the importance of E3908.49b for all three signal transduction pathways, for the CGRP receptor, but mutations of other residues largely just altered ERK1/2 activation. Thus, ICL1 may modulate GPCR bias via interactions with ICL2, ICL4 and the Gß subunit.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Glucagon / Receptores de Hormônio Liberador da Corticotropina / Receptores de Peptídeo Relacionado com o Gene de Calcitonina / Motivos de Aminoácidos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Glucagon / Receptores de Hormônio Liberador da Corticotropina / Receptores de Peptídeo Relacionado com o Gene de Calcitonina / Motivos de Aminoácidos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article